Skip to main content

Table 2 The cycle characteristics of controlled ovarian stimulation in the two groups

From: Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome

 

Study group

(HMG + MPA + CC; n = 110)

Control group

(HMG + MPA; n = 110)

P value

hMG doses (IU)

1470.0 ± 360.1

1943.8 ± 372.0

< 0.001

hMG duration (days)

9.2 ± 1.3

9.1 ± 1.2

0.594

No. of > 10 mm follicles on trigger day

17.6 ± 8.4

21.2 ± 8.3

0.001

No. of > 14 mm follicles on trigger day

13.8 ± 8.4

17.2 ± 9.3

0.004

No. of oocytes retrieved(n)

12.2 ± 7.4

18.2 ± 9.7

< 0.001

No. of maturation oocytes (n)

10.7 ± 6.3

14.6 ± 8.2

< 0.001

No. of fertilization (n)

8.6 ± 5.6

12.6 ± 7.7

< 0.001

No. of viable embryos(n)

4.8 ± 3.5

6.2 ± 3.7

0.007

Oocyte retrieval rate (%)

58.8% (1343/2285)

60.1% (2006/3335)

0.302

Oocyte maturation rate (%)

87.4% (1174/1343)

80.3% (1610/2006)

< 0.001

The proportion of viable embryo per oocyte retrieved (%)

39.5% (531/1343)

33.8% (678/2006)

0.001

Cancellation for no viable embryos (%)

9.1% (10/110)

1.8% (2/110)

0.018

Incidence of moderate/severe OHSS (%)

0.91% (1/110)

0.91% (1/110)

1.00